URGN icon

UroGen Pharma
URGN

Overview Fund Activity

63 hedge funds and large institutions have $413M invested in UroGen Pharma in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-8
Holders Change %
-11.27%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
25
Reduced
19
Closed
15
Calls
$348K
Puts
–
Net Calls
+$348K
Net Calls Change
+$707K

Top Buyers

1
WCM
Wildcat Capital Management
New York
+$10.2M
2
BlackRock
BlackRock
New York
+$8.5M
3
HCM
Highline Capital Management
New York
+$5.59M
4
CI
Clal Insurance
Israel
+$3.84M
5
DG
Delek Group
Israel
+$2.82M

Top Sellers

1
MIH
Meitav Investment House
Israel
-$7.13M
2
Millennium Management
Millennium Management
New York
-$5.32M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$888K
4
MAP
Moody Aldrich Partners
Massachusetts
-$860K
5
Renaissance Technologies
Renaissance Technologies
New York
-$793K
Name Holding Trade Value Shares
Change 		Shares
Change %
Arrowstreet Capital
76
Arrowstreet Capital
Massachusetts
– -$91K -1,932 Closed
Group One Trading
77
Group One Trading
Illinois
– -$9K -180 Closed
Federated Hermes
78
Federated Hermes
Pennsylvania
– -$1K -6 Closed
1 2 3
4